
Feature|Articles|August 5, 2026
Bringing the Gulani classification to life: 4 pathways to the same destination
Fact checked by: Lucia Gambuzza
In part 2 of a 2-part article, Arun C. Gulani, MD, walks through the 4 patient types of the Gulani classification of refractive lens exchange, from primary vision enhancement to staged vision engineering, and explains why outcomes depend on treating the eye as a complete optical system rather than on the implant alone.
Advertisement
Advertisement
Editor's note: This is Part 2 of a 2-part article on the Gulani classification of refractive lens exchange. Part 1, which introduced the classification's framework, was published on OphthalmologyTimes.com on July 29, 2026.
Related to this article

David F. Chang, MD, shares how to set realistic refractive IOL expectations and streamline patient counseling.

Rheumatoid arthritis, is an autoimmune disorder, develops more often in women than men in a 3:1 ratio.

Murtaza K. Adam, MD, shares pearls on haptic docking, patient selection, and preventing complications with the Yamane technique.

The epidemiology, inflammatory pathophysiology, diagnosis, and treatment of diabetic macular edema are discussed during Inflammatory Eye Disease Week.

Prevent Blindness marks IED Week, October 19 to 25, as new therapies and pivotal trials reshape care for uveitis and thyroid eye disease.

Interim 48-month data show 86% of patients with glaucoma or ocular hypertension remain off topical drops after a single cataract procedure, although the drop-free rate has eased from earlier timepoints.

At AAO 2026, Anjum F. Koreishi, MD, shared how to prevent complications after cataract surgery in patients with uveitis.
Advertisement
Advertisement

